Luis D. Carcorze Soto, MD PGY-3
|
|
- Elinor Barber
- 2 years ago
- Views:
Transcription
1 Luis D. Carcorze Soto, MD PGY-3
2 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC
3 Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic: Appendiceal Colorectal Gastric Pancreatic Ovarian
4 Type of Malignancy Estimated Annual Incidence in U.S. Primary peritoneal cancer Malignant peritoneal mesothelioma Appendiceal cancer Colorectal cancer 146,970 31,000 Gastric cancer 21,130 10,000 Ovarian cancer 21,550 18,000 Pancreatic cancer 42, Endometrial cancer 42, Estimated Annual Incidence of Peritoneal Involvement
5 Serosal membrane Single layer of flat mesothelial cells supported by submesothelial connective tissue.
6
7
8 Right upper quadrant and porta hepatis Omentum, spleen, and lesser sac Left upper quadrant and stomach Colon and colic gutters Small bowel and mesentery Pelvic peritoneum and pelvic organs
9 Age Comorbidities Type of Malignancy Extent of Disease
10 Disease or Condition Example Accepted Under Investigation Noninvasive peritoneal carcinomatosis, any volume Pseudomyxoma peritonei X Malignant peritoneal mesothelioma (MPM), any volume MPM Invasive cancer, low volume Colorectal cancer X X Gastrointestinal cancer with positive cytology or perforation Gastric cancer X Recurrent ovarian cancer unresponsive to systemic chemotherapy Recurrent ovarian cancer X Gastrointestinal cancer with invasion of adjacent organs or positive margins Colorectal cancer X Ovarian cancer, initial diagnosis of stage IIIB or IIIC Ovarian cancer X Malignant ascites (for palliation) Pancreatic cancer X Noninvasive sarcomatosis, any volume Recurrent retroperitoneal fibrosarcoma X
11
12
13 Remove all visible disease Remove Affected Peritoneum
14 1. Greater omentectomy and splenectomy 2. Left subdiaphragmatic peritonectomy 3. Right subdiaphragmatic peritonectomy 4. Lesser omentectomy and cholecystectomy with stripping of the omental bursa 5. Complete pelvic peritonectomy 6. Partial or complete gastrectomy
15
16 1. Greater omentectomy and splenectomy 2. Left subdiaphragmatic peritonectomy 3. Right subdiaphragmatic peritonectomy 4. Lesser omentectomy and cholecystectomy with stripping of the omental bursa 5. Complete pelvic peritonectomy 6. Partial or complete gastrectomy
17
18
19 1. Greater omentectomy and splenectomy 2. Left subdiaphragmatic peritonectomy 3. Right subdiaphragmatic peritonectomy 4. Lesser omentectomy and cholecystectomy with stripping of the omental bursa 5. Complete pelvic peritonectomy 6. Partial or complete gastrectomy
20
21
22
23 1. Greater omentectomy and splenectomy 2. Left subdiaphragmatic peritonectomy 3. Right subdiaphragmatic peritonectomy 4. Lesser omentectomy and cholecystectomy with stripping of the omental bursa 5. Complete pelvic peritonectomy 6. Partial or complete gastrectomy
24
25
26 1. Greater omentectomy and splenectomy 2. Left subdiaphragmatic peritonectomy 3. Right subdiaphragmatic peritonectomy 4. Lesser omentectomy and cholecystectomy with stripping of the omental bursa 5. Complete pelvic peritonectomy 6. Partial or complete gastrectomy
27
28
29 Hyperthermic IntraPEritoneal Chemotherapy Why Hyperthermic? Heat increases drug penetration into tissue. Heat increases the cytotoxicity of selected chemotherapy agents. Heat has anti-tumor effects by itself. Intraoperative chemotherapy allows manual distribution of drug and heat uniformly to all surfaces of the abdomen and pelvis. Renal toxicities of chemotherapy can be avoided by careful monitoring of urine output during chemotherapy perfusion. Nausea and vomiting are avoided because the patient is under general anesthesia. The time that elapses during the heated perfusion allows a normalization of many functional parameters (temperature, blood clotting, hemodynamics, etc.).
30 Both Prolonged Survival, Disease free time. Under investigation HIPEC vs EPIC vs HIPEC and EPIC
31
32
33 Annals of Surgery Paul H. Sugarbaker, and Kathleen Jablonski From the Washington Cancer Institute, Washington Hospital Center, and Medlantic Research Institute
34 Appendix vs Colon Grade Complete vs Incomplete Cytoreduction Lymph Node Metastasis
35 Prognostic Feature 3-year Survival P-value Appendix 73% Colon 36% Grade 1 81% Other Grade 41% Complete 82% Incomplete 20% Met Positive 70% Mets Negative 37% Volume Mod 75% Volume Large 20%
36 Vic J. Verwaal, 2003 Journal of Clinical Oncology, Department of Surgery Biometric and Gastroenterology Netherlands Cancer Institute
37
38 Randomized Study between , 105 patients Cytoreduction followed by HIPEC significantly reduced the risk of dying ( hazard ratio, 0.55; 95% CI, ).32 to 0.95; log rank P= 0.032) Median Surgical in the standard group was 12.6 months and in the experimental group 22.4 months
Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA
Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy
PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/f Colorectal: Cytoreductive surgery (Adult)
A08/S/f 2013/14 NHS STANDARD CONTRACT FOR COLORECTAL: CYTOREDUCTIVE SURGERY (ADULT) PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Part of an Integrative Treatment Plan for Colorectal Peritoneal Carcinomatosis
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Part of an Integrative Treatment Plan for Colorectal Peritoneal Carcinomatosis T. Christopher Windham, M.D., F.A.C.S. Medical Director, Florida Hospital
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
Chirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison
Peritoneal dissection and intraperitoneal chemotherapy under hyperthermic conditions. If you select the right patients long-term survival can be achieved. Chirurgia Avanzata Del Carcinoma Ovarico Nuove
Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma
Medical Policy Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pseudomyxoma Peritonei and Peritoneal Carcinomatosis of Gastrointestinal Origin, and Peritoneal Mesothelioma
Corporate Medical Policy
Corporate Medical Policy Hyperthermic Intraperitoneal Chemotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperthermic_intraperitoneal_chemotherapy 5/19/2005 3/2016 3/2017
Comments: Policy Accepted during 2013 Annual Review with no changes.
Health Plan Coverage Policy ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 09/18/2013 Title: Cytoreduction Surgery with Hyperthermic Intraperitoneal Chemotherapy Comments: Policy
PERITONEAL THERAPY IN OVARIAN CANCER, ROBERT P. EDWARDS, MD 1
PERITONEAL THERAPY IN OVARIAN CANCER, ROBERT P. EDWARDS, MD 1 Good morning, my name is Dr. Robert Edwards and I m going to be discussing peritoneal therapy in the treatment of women with ovarian cancer.
Peritoneal Carcinosis
Peritoneal Carcinosis What is it and how to cure it Peritoneum Peritoneum is a thin and transparent membrane that covers the internal part of the abdominal and pelvic cavity and all the viscera contained
Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface
J. Exp. Clin. Cancer Res., 22, 4, 2003 - Supplement Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface Malignancy Yan T.D., Esquivel J., Carmignani
Peritoneal Carcinomatosis: Pathophysiology, Prevention, and Treatment
Peritoneal Carcinomatosis: Pathophysiology, Prevention, and Treatment Wim Ceelen, MD, PhD, FACS GI Surgery, UZ Gent KAGB 27/4/2013 Overview What is peritoneal carcinomatosis? Rationale for IP drug delivery
Cytoreductive surgery in Ovarian Cancer. Arjun Jeyarajah, Consultant Gynaecological Oncologist, St Bartholomew s Hospital, London.
Cytoreductive surgery in Ovarian Cancer Arjun Jeyarajah, Consultant Gynaecological Oncologist, St Bartholomew s Hospital, London. Ovarian Cancer 6,600 new cases per year 4,000 deaths 75% of cases have
Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England B03/P/a 1 Information Reader Box (IRB) to be inserted
H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
Role of surgery in the management of Ovarian cancer. Waseem Kamran Sub-speciality Fellow Surgical Gynaecological Oncology St James Hospital
Role of surgery in the management of Ovarian cancer Waseem Kamran Sub-speciality Fellow Surgical Gynaecological Oncology St James Hospital Role of surgery Prevention Diagnosis Staging Treatment Palliative
Surgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Clinical Commissioning Policy: Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England A08/P/c 2 NHS England INFORMATION READER BOX Directorate
Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure
Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure Eddy Cotte, Brigitte Tranchand, Annie-Claude Beaujard, François-Noël
National Medical Policy
National Medical Policy Subject: Policy Number: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers NMP346 Effective Date*: June 2007 Updated: November 2014 This National Medical Policy
Peritoneal tumour service. Information for patients
Peritoneal tumour service Hyperthermic intraperitoneal chemotherapy (HIPEC) Information for patients Chemotherapy given into the abdomen during surgery is called intraoperative chemotherapy. This information
PROGNOSTIC FACTORS IN ADVANSED OVARIAN CANCER
PROGNOSTIC FACTORS IN ADVANSED OVARIAN CANCER Dr. Hisham Rahahle Gynecologist, MD, Ph.D Subspecialty in Gynecological Oncology E-mail: hisham_re@yahoo.com Abstract: This study includes (68) patient diagnosed
Frequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
A succesfull case of HIPEC in a peritoneal mesothelioma patient
A succesfull case of HIPEC in a peritoneal mesothelioma patient Firmino, NLJ¹²; Miranda, E¹³; Oliveira, DA ²; Lima, MBA ¹²; Diniz, AF ¹²; Gomes, GES ¹²; Azevedo, LW ¹²; Soares,MC¹²; Gomes, ASA³. ¹Pernambuco
Quick Facts about Appendix Cancer
Quick Facts about Appendix Cancer What is the appendix? The appendix is a pouch-like tube attached to the first part of the large intestine (cecum). The appendix is about 10 centimetres long and has no
Epithelial Ovarian Cancer
Epithelial Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Risk Factors Incessant ovulation Early menarche, late menopause, low parity Family history Acquired genetic mutations
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma
Original Article 291 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma Grace HC Tan, 1 MBBS (London), MRCS (Edinburgh), Michelle Cheung, 1 MBBCh
O. Glehen 1,2, E. Cotte 1,2, J. C. Lifante 1,2, C. Arvieux 2,3, N. Moles 1, C. Brigand 2,4, A. C. Beaujard 1,2, Y. François 1,2, F. N.
Acta chir belg, 2006, 106, 285-290 Peritoneal Carcinomatosis in Digestive Cancers : Cytoreductive Surgery Combined with Intraperitoneal Chemohyperthermia. The Experience in Centre Hospitalier et Universitaire
ESSO Course on Peritoneal Surface Malignancy
ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology 08-09 October 2015 MANCHESTER (UK) ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The
4 th Edition Paul H. Sugarbaker, MD, FACS, FRCS
December 5, 2005 Technical Handbook for the Integration of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy into the Surgical Management of Gastrointestinal and Gynecologic Malignancy
Costing statement: Ovarian cancer: the recognition and initial management of ovarian cancer
Costing statement: Ovarian cancer: the recognition and initial management of ovarian cancer 1 Resource impact The guideline on ovarian cancer (NICE clinical guideline 122) is unlikely to have a significant
Keywords: advanced stage ovarian cancer, tertiary cytoreduction, debulking surgery
CASE PRESENTATION ROJSP 2016, Vol. I (issue 1): E 45-53. Extended upper abdominal resections as part of debulking surgery at the time of tertiary cytoreduction for relapsed ovarian cancer a case report
IN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment
Sugarbaker, Cancerología 3 (2008): 119-124 1 Washington Cancer Institute, Washington, DC, USA Overview of Peritoneal Carcinomatosis Paul H. Sugarbaker 1 Abstract IN MANY PATIENTS WITH ABDOMINAL OR PELVIC
ABDOMINAL CANCER WITH PERITONEAL CARCINOMATOSIS TREATED BY PERITONECTOMY PROCEDURE AND INTRAPERITONEAL CHEMOHYPERTHERMIA
Experimental Oncology 22, 59-63, 2000 (March) 59 ABDOMINAL CANCER WITH PERITONEAL CARCINOMATOSIS TREATED BY PERITONECTOMY PROCEDURE AND INTRAPERITONEAL CHEMOHYPERTHERMIA O. Glehen 1 2, *, P. Peyrat 1,
Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies
DOI 10.1007/s00384-007-0313-z ORIGINAL ARTICLE Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies P. Piso
POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT Written by: Karyn Varley MS, SCT(ASCP) The donating laboratory would like to remain anonymous. PATIENT HISTORY 28 year old female Lived
Hospital: IRB #: Principal Phone Fax Email Investigator: Dr. A. Co-investigators: Dr. C Dr. D Dr. E Dr. F
Title: Protocol for the Implementation of Treatment of Patients with Peritoneal Surface Malignancy with Hyperthermic Intraoperative Intraperitoneal Chemotherapy and Normothermic Early Postoperative Intraperitoneal
MR Imaging of Peritoneal Malignancy Russell N. Low, MD
MR Imaging of Peritoneal Malignancy Russell N. Low, MD From: Sharp and Children's MRI Center and Sharp HealthCare, 7901 Frost Street, San Diego, California, 92123. Phone: (858) 939-3600. Email: rlow@ucsd.edu
INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)
MEDICAL POLICY INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Policy Number: CS141.A Effective Date: September 1, 2015 Table of Contents COVERAGE RATIONALE DEFINITIONS... APPLICABLE CODES..
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER
COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards
Laparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature
Ann Surg Oncol DOI 10.1245/s10434-012-2360-0 ORIGINAL ARTICLE REVIEW ARTICLE Laparoscopic Hyperthermic Intra Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature Enrico Facchiano,
Rachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris *
Send Orders for Reprints to reprints@benthamscience.net The Open Surgical Oncology Journal, 2014, 5, 1-5 1 Open Access Avoidance of Early Post-Operative Intraperitoneal Chemotherapy (EPIC) Following Peritonectomy
Management of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives. Dominique ELIAS
Management of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives Dominique ELIAS Declaration of interest BOARDS Congress and teaching 0 Merck 0 Ipsen Novartis Sanofi Trials The peritoneum
Robotics in the Modern Era of Ovarian Cancer Management
Robotics in the Modern Era of Ovarian Cancer Management Ginger J. Gardner, MD Gynecology Service, Department of Surgery Memorial Sloan-Kettering Cancer Center Objectives Advantages of Minimally Invasive
Gastrointestinal Oncology Peritoneal Mesothelioma
Gastrointestinal Oncology Two Decades of Progress in the Management of a Rare Disease Paul H Sugarbaker, MD, FACS, FRCS Medical Director, Center for Gastrointestinal Malignancies, MedStar Washington Hospital
Columbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org
Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental
Overview of Gynaecologic Cancer
Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms
New strategies in anticancer therapy
癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive
Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma
EJSO 2002; 28: 80 87 doi:10.1053/ejso.2001.1152, available online at http://www.idealibrary.com on EDUCATIONAL SECTION Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis,
Ovarian Cancer. Josie Rutovitz
Ovarian Cancer Josie Rutovitz Extent of the Problem In 2006 = 9 th most common cancer in women (Aust Institute of Health and Welfare). 1226 new cases in 2006. 60% of cases are post menopausal. 47% increase
Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda
Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
Sybile Val, MD Department of Surgery. October 29, 2009
Soft Tissue Tumors Sybile Val, MD Department of Surgery SUNY Downstate Medical Center October 29, 2009 Case Presentation 52 YOM presented to ED on 7/22 with 52 YOM presented to ED on 7/22 with abdominal
Clinical Policy Bulletin: Hyperthermia in Cancer Therapy
Hyperthermia in Cancer Therapy Page 1 of 28 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Hyperthermia in Cancer Therapy Number:
Ovarian Cancer. Andreas Obermair. Gynaecological Oncologist
Ovarian Cancer Andreas Obermair Gynaecological Oncologist www.obermair.info Ovarian cancer in QLD Five patients with ovarian cancer per week in QLD. Two patients will be diagnosed in early stage (stage
California Cancer Registry 2010 Gastrointestinal Stromal Tumor (GIST) Recoding Audit CCR Project ID #300.66 Final Report Revised July 11, 2011
The Data Standards and Quality Control Unit (DSQC) of the California Cancer Registry (CCR) initiated an audit of Gastrointestinal Stromal Tumors (GIST) cases due to an identified issue on a Patterns of
EXTENSIVE DEBULKING SURGERY FOR ADVANCED STAGE OVARIAN CANCER. Jafaru Abu. Consultant gynaecological oncologist
1 EXTENSIVE DEBULKING SURGERY FOR ADVANCED STAGE OVARIAN CANCER Jafaru Abu Consultant gynaecological oncologist Nottingham University Hospital Cancer Centre Nottingham 2015 2 Contents: Introduction NICE
Pseudomyxoma Peritonei Where are we in 2014?
Pseudomyxoma Peritonei Where are we in 2014? Santiago González-Moreno, MD, PhD Head, Department of GI Surgical Oncology Peritoneal Surface Oncology Program Medical Director * * * * * * * * * * * * French
A WOMAN S GUIDE foundationforwomenscancer.org
Understanding Primary Peritoneal Cancer A WOMAN S GUIDE foundationforwomenscancer.org CONTENTS INTRODUCTION...1 PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCERS: AN OVERVIEW...2 RISK FACTORS...3 SYMPTOMS...3
Avastin: Glossary of key terms
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of ultra-radical (extensive) surgery for advanced ovarian cancer Treating advanced
Hyperthermia in Cancer Treatment: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Hyperthermia in Cancer
Uterine sarcomas are very rare. They are responsible for only 1 to 5 percent of all malignancies
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
Huang et al. World Journal of Surgical Oncology (2015) 13:262 DOI 10.1186/s12957-015-0682-7 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Cytoreductive surgery and perioperative intraperitoneal chemotherapy
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)
INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Protocol: SUR052 Effective Date: September 1, 2015 Table of Contents Page COMMERCIAL, MEDICARE AND MEDICAID COVERAGE RATIONALE... 1 DEFINITIONS...
CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES
CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors
Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei
Health Technology Assessment 2004; Vol. 8: No. 7 Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei J Bryant, AJ Clegg, MK Sidhu, H Brodin, P Royle
Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32
Diseases of peritoneum Lect Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Describe the etiology, pathogenesis and types of peritonitis Define ascites and
Neoadjuvant radiotherapy: Necessary for treatment of rectal cancer. Shannon Acker April 4, 2011
Neoadjuvant radiotherapy: Necessary for treatment of rectal cancer Shannon Acker April 4, 2011 Rectal Cancer 40,870 new cases in the US in 2009 49,920 deaths from colorectal cancer Second leading cause
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
Omental mesothelioma as a diagnostic and therapeutic challenge: A case report
www.edoriumjournals.com Case in Images OPEN ACCESS Omental mesothelioma as a diagnostic and therapeutic challenge: A case report Cihan Akgul Ozmen, Yekta Tuzun, Hatice Ozturkmen Akay, Hasan Nazaroglu ABSTRACT
CASE 04/04/2016 CUT THRU EVERY LOCULE AND SAMPLE ANYTHING THAT LOOKS DIFFERENT GROSS EXAM: SAMPLE, SAMPLE, SAMPLE
CASE 22 YOF G2P1 SVD US: LARGE COMPLEX OVARIAN MASS WITH NODULAR COMPONENT LFU; ADMITTED TO ER WITH SEVERE ABDOMINOPELVIC PAIN EXPLOR LAP LARGE CYST FILLED ABDOM/PELVIS RUPTURED AT REMOVAL & SPILLED 7500
Ovarian, Fallopian Tube, and Peritoneal Cancer - Treatment Options [1]
Home > Types of Cancer > Ovarian, Fallopian Tube, and Peritoneal Cancer > Ovarian, Fallopian Tube, and Peritoneal Cancer - Treatment Options PDF generated on September 2, 2016 from http://www.cancer.net/cancer-types/ovarian-fallopian-tube-andperitoneal-cancer/treatment-options
Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Dario Baratti, Alessandro Scivales, Maria Rosaria Balestra, Patrizia Ponzi, Francesca
Gestational Trophoblastic Tumors
32 Gestational Trophoblastic Tumors C58.9 Placenta SUMMARY OF CHANGES Gestational trophoblastic tumors are effectively treated with chemotherapy even when widely metastatic so that traditional anatomic
Gallbladder cancer is a disease in which malignant (cancer) cells form in the tissues of the gallbladder.
Gallbladder cancer Gallbladder cancer is a disease in which malignant (cancer) cells form in the tissues of the gallbladder. Gallbladder cancer is a rare disease in which malignant (cancer) cells are found
What is ovarian cancer and how common is it?
Information for you Published in January 2016 (next review date: 2019) Ovarian cancer Who is this information for? This information is for you if you have ovarian cancer or want to know more about it.
Yue Zhu, Nader Hanna, Cherif Boutros, H. Richard Alexander Jr. Background
Review Article Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases Yue
Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
NEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
Examination of Racial Disparities in Epithelial Ovarian Cancer Survival
Examination of Racial Disparities in Epithelial Ovarian Cancer Survival Jennifer Todd A, Martin Whiteside B, Paul Terry C A Meharry Medical College, School of Graduate Studies and Research B Tennessee
Liver Cancer What is the liver? What is liver cancer?
Liver Cancer What is the liver? The liver is the largest internal organ in the body and is important in digesting food. The liver performs many other functions, including collecting and filtering blood
Selection of patients and staging of peritoneal surface malignancies
Online Submissions: http://www.wjgnet.com/1948-5204office wjgo@wjgnet.com doi:10.4251/wjgo.v2.i1.31 World J Gastrointest Oncol 2010 January 15; 2(1): 31-35 ISSN 1948-5204 (online) 2010 Baishideng. All
INDIAN JOURNAL OF MEDICAL & PAEDIATRIC ONCOLOGY Vol. 28 No 1, 2007 1 4
INDIAN JOURNAL OF MEDICAL & PAEDIATRIC ONCOLOGY Vol. 28 No 1, 2007 1 4 Original Article-II Primary Versus Interval Cytoreductive Surgery in Treatment of Advanced Ovarian Cancer ABDUL RASHID LONE, MUSHTAQ
Mesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
Post-operative intrapleural chemotherapy for mesothelioma
Post-operative intrapleural chemotherapy for mesothelioma Robert Kratzke, MD John Skoglund Chair for Lung Cancer Research Section of Heme-Onc-Transplant University of Minnesota Medical School Efficacy
Recent Advances in the Surgical Management of Ovarian Cancer
Recent Advances in the Surgical Management of Ovarian Cancer Neil S. Horowitz, M.D. Assistant Professor, Harvard Medical School Division of Gynecologic Oncology Brigham and Women s/dana Farber Ovarian
Evidence tabel Lokaal palliatieve behandelingen
Auteurs, jaartal Mate van bewijs Studie type Follow-up Populatie (incl. steekproef-grootte) Patienten kenmerken Interventie Controle Resultaten Conclusie Opmerkingen, commentaar Hartgrink, 2002 The Netherlands
Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
Oncologist. The. Clinical Pharmacology. Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy
The Oncologist Clinical Pharmacology Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy PAUL H. SUGARBAKER, a JORGE TORRES MORA, b PABLO CARMIGNANI, a O. ANTHONY